Immunotherapy is increasingly becoming standard therapy in cancer, with technology, such as checkpoint inhibitors and cell therapy, raising the efficacy bar in many forms of the disease. But the ...

With the community hailing the latest FDA-approved therapeutic with Novartis’ inhibitor of the alternative complement for PNH, which inhibitor will be the next to harness the complement system for the ...

Bringing together traditional Chinese medicine and contemporary medicine could improve outcomes for patients with chronic disease. In this Q&A, Lidian Chen, professor and chief physician at Fujian ...

Project mBridge -- a cross-border platform for experimenting with central bank digital currencies for international trade -- does not exclude the use of the dollar and will focus on facilitating ...